in this issue
Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients
Ranbaxy Launches Generic Version of Lipitor
December 6, 2011 | Deepti Ramesh
The U.S. Food and Drug Administration (FDA) has approved the first generic version of Pfizer’s cholesterol-lowering drug Lipitor - atorvastatin calcium tablets. Ranbaxy Pharmaceuticals (Jacksonville, FL) USA, a subsidiary of Ranbaxy Laboratories (Gurgaon, India) received final approval from the FDA to manufacture and market atorvastatin and has launched the product in the U.S. market on December 1. Lipitor, the top-selling drug, generates annual sales of about $7.89 billion in the U.S., Ranbaxy says. Ranbaxy has gained approval to make generic atorvastatin...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee